Koyfin Home > Directory > Health Care > Acorda Therapeutics > Total Debt / (EBITDA-CAPEX)

Acorda Therapeutics Total Debt / (EBITDA-CAPEX) Chart (ACOR)

Acorda Therapeutics annual/quarterly Total Debt / (EBITDA-CAPEX) from 2010 to 2020.
  • Acorda Therapeutics Total Debt / (EBITDA-CAPEX) for the quarter ending June 06, 2020 was $-5m a 49.20% decrease of -2m year over year
  • Acorda Therapeutics Total Debt / (EBITDA-CAPEX) for the last 12 months ending June 06, 2020 was $-3m a 21.56% decrease of -1m year over year
  • Acorda Therapeutics Annual Total Debt / (EBITDA-CAPEX) for 2019 was $-2m a 405.00% decrease of -6m from 2018
  • Acorda Therapeutics Annual Total Debt / (EBITDA-CAPEX) for 2018 was $5m a 42.27% increase of 2m from 2017
  • Acorda Therapeutics Annual Total Debt / (EBITDA-CAPEX) for 2017 was $3m a -2,048.96% decrease of -56m from 2016
Other Ratios Metrics:
  • Acorda Therapeutics Total Debt / Capital for the quarter ending December 12, 2018 was $36m a -5.79% decrease of -2m year over year
  • Acorda Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $204m a 10.59% increase of 22m year over year
  • Acorda Therapeutics Total Debt / Equity for the quarter ending December 12, 2018 was $56m a -9.35% decrease of -5m year over year
View Chart On Koyfin

Quarterly ACOR Total Debt / (EBITDA-CAPEX) Data

06/2020$-5m
03/2020$-3m
12/2019$-5m
09/2019$-2m
06/2019$-2m
03/2019$-2m
12/2018$-4m
09/2018$2m
06/2018$2m
03/2018$16m

Annual ACOR Total Debt / (EBITDA-CAPEX) Data

2019$-2m
2018$5m
2017$3m
2016$59m
2015$5m
2014$6m
2013$0m
2012$0m
2011$0m
2010$-1m